Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Harbinger Group Inc (HRG): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

Should Harbinger Group Inc (NYSE:HRG) investors track the following data?

In today’s marketplace, there are dozens of methods shareholders can use to analyze publicly traded companies. Some of the most useful are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best money managers can outpace their index-focused peers by a very impressive amount (see just how much).

Equally as crucial, optimistic insider trading activity is another way to analyze the financial markets. As the old adage goes: there are a variety of incentives for an insider to cut shares of his or her company, but only one, very obvious reason why they would behave bullishly. Many empirical studies have demonstrated the useful potential of this method if investors understand where to look (learn more here).

What’s more, it’s important to study the newest info surrounding Harbinger Group Inc (NYSE:HRG).

How have hedgies been trading Harbinger Group Inc (NYSE:HRG)?

At the end of the second quarter, a total of 16 of the hedge funds we track were long in this stock, a change of 45% from the first quarter. With the smart money’s capital changing hands, there exists a few key hedge fund managers who were increasing their holdings meaningfully.

Harbinger Group Inc (NYSE:HRG)According to our 13F database, Harbinger, managed by Phil Falcone, holds the largest position in Harbinger Group Inc (NYSE:HRG). Harbinger has a $729.6 million position in the stock, comprising 29% of its 13F portfolio. Coming in second is Leon Cooperman of Omega Advisors, with a $37.7 million position; the fund has 0.6% of its 13F portfolio invested in the stock. Remaining hedge funds that hold long positions include James H. Litinsky’s JHL Capital Group, Chuck Royce’s Royce & Associates and James Pallotta’s Raptor Capital Management.

As industrywide interest increased, certain bigger names were leading the bulls’ herd. Harbinger, managed by Phil Falcone, assembled the biggest position in Harbinger Group Inc (NYSE:HRG). Harbinger had 729.6 million invested in the company at the end of the quarter. Leon Cooperman’s Omega Advisors also initiated a $37.7 million position during the quarter. The other funds with brand new HRG positions are James H. Litinsky’s JHL Capital Group, Chuck Royce’s Royce & Associates, and James Pallotta’s Raptor Capital Management.

What have insiders been doing with Harbinger Group Inc (NYSE:HRG)?

Legal insider trading, particularly when it’s bullish, is at its handiest when the company in focus has experienced transactions within the past half-year. Over the latest six-month time period, Harbinger Group Inc (NYSE:HRG) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Harbinger Group Inc (NYSE:HRG). These stocks are Hyde Park Acquisition Corp II (NASDAQ:HPAC), New Mountain Finance Corp. (NYSE:NMFC), Lydall, Inc. (NYSE:LDL), Steel Partners Holdings LP (NYSE:SPLP), and Global Eagle Acquisition Corp (NASDAQ:ENT). All of these stocks are in the conglomerates industry and their market caps match HRG’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!